Massive eye study reveals rare inflammation risk from common drug
NCT ID NCT06769412
First seen Nov 01, 2025 · Last updated May 12, 2026 · Updated 34 times
Summary
This study looked at how often retinal vasculitis (a rare eye inflammation) occurs in people receiving Eylea injections for eye diseases. Researchers reviewed medical records of over 550,000 patients in the US to count cases and confirm them. The goal was to better understand the safety of this common treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RETINAL VASCULITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Regeneron Research Site
Tarrytown, New York, 10591, United States
Conditions
Explore the condition pages connected to this study.